Stock listing
NASDAQ:CBLL CeriBell, Inc. Stock
Home listing (NASDAQ) of CeriBell, Inc.
Follow CeriBell, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CBLL
$27.39 USD +1.76 (+6.9%)
Close on Nov 20, 2026
- Day range
- $25.58 – $27.45 USDNov 20, 2026
- Volume
- 655,910 sharesNov 20, 2026
- Market cap
- $1.06B USDAt the close on Nov 20, 2026 · price × 38.84M shares outstanding
- 52-week range
- $13.61 – $28.89 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $11.49M USDMedian day 336,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CBLL · Home | $27.39 USD | +1.76 (+6.9%) | 655,910 | $25.67 | $27.45 | $25.58 | $25.63 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CBLL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $27.39 | +1.76 | +6.9% | $25.67 | $27.45 | $25.58 | 655,910 | |
| $25.63 | -0.34 | -1.3% | $25.80 | $26.21 | $25.20 | 410,346 | |
| $25.97 | -0.45 | -1.7% | $26.39 | $26.82 | $25.91 | 428,154 | |
| $26.42 | +0.28 | +1.1% | $26.09 | $26.46 | $25.60 | 770,439 | |
| $26.14 | -0.21 | -0.8% | $26.20 | $26.41 | $25.86 | 267,633 | |
| $26.35 | -1.45 | -5.2% | $27.60 | $27.71 | $26.29 | 480,055 | |
| $27.80 | +0.32 | +1.2% | $27.79 | $28.27 | $27.58 | 232,752 | |
| $27.48 | -0.12 | -0.4% | $27.47 | $27.94 | $27.02 | 327,271 | |
| $27.60 | +1.01 | +3.8% | $26.68 | $27.70 | $26.68 | 338,239 | |
| $26.59 | +0.58 | +2.2% | $25.67 | $26.79 | $24.87 | 436,387 | |
| $26.01 | -1.38 | -5.0% | $27.39 | $28.00 | $25.81 | 955,784 | |
| $27.39 | -0.88 | -3.1% | $22.05 | $28.28 | $21.85 | 1,271,933 | |
| $28.27 | +1.31 | +4.9% | $27.11 | $28.89 | $26.87 | 665,677 | |
| $26.96 | +0.38 | +1.4% | $26.96 | $27.54 | $26.82 | 912,649 | |
| $26.58 | -1.24 | -4.5% | $27.48 | $27.61 | $26.01 | 582,651 | |
| $27.82 | +0.60 | +2.2% | $27.00 | $28.19 | $27.00 | 405,299 | |
| $27.22 | 0.00 | 0.0% | $27.22 | $27.60 | $26.81 | 742,942 | |
| $27.22 | +0.19 | +0.7% | $27.17 | $27.71 | $26.67 | 1,158,847 | |
| $27.03 | -0.10 | -0.4% | $27.21 | $27.63 | $26.98 | 311,591 | |
| $27.13 | -0.27 | -1.0% | $27.24 | $27.80 | $26.29 | 496,799 | |
| $27.40 | +0.26 | +1.0% | $27.00 | $27.87 | $26.77 | 368,294 | |
| $27.14 | -0.54 | -2.0% | $27.64 | $28.11 | $27.01 | 472,006 | |
| $27.68 | +1.68 | +6.5% | $26.00 | $27.91 | $26.00 | 593,250 | |
| $26.00 | +0.96 | +3.8% | $25.05 | $26.51 | $24.62 | 633,560 | |
| $25.04 | -2.60 | -9.4% | $27.48 | $27.48 | $24.86 | 406,900 | |
| $27.64 | +1.27 | +4.8% | $26.50 | $27.94 | $25.85 | 911,800 | |
| $26.37 | +0.23 | +0.9% | $25.78 | $26.72 | $25.00 | 887,600 | |
| $26.14 | +0.88 | +3.5% | $25.35 | $26.63 | $24.90 | 542,700 | |
| $25.26 | +1.63 | +6.9% | $23.77 | $25.27 | $23.27 | 696,900 | |
| $23.63 | +0.48 | +2.1% | $23.03 | $23.85 | $22.90 | 325,300 | |
| $23.15 | -0.33 | -1.4% | $23.40 | $23.40 | $22.62 | 243,800 | |
| $23.48 | -0.86 | -3.5% | $24.20 | $24.55 | $23.43 | 305,400 | |
| $24.34 | -0.52 | -2.1% | $24.95 | $25.10 | $24.22 | 241,700 | |
| $24.86 | +1.17 | +4.9% | $23.67 | $25.05 | $23.67 | 239,500 | |
| $23.69 | +0.08 | +0.3% | $24.18 | $24.19 | $23.32 | 307,000 | |
| $23.61 | -0.78 | -3.2% | $24.38 | $24.54 | $23.50 | 316,700 | |
| $24.39 | -0.47 | -1.9% | $25.00 | $25.25 | $24.36 | 336,100 | |
| $24.86 | +0.35 | +1.4% | $24.51 | $24.90 | $24.03 | 300,900 | |
| $24.51 | +0.82 | +3.5% | $23.61 | $24.59 | $23.52 | 216,700 | |
| $23.69 | -0.13 | -0.5% | $23.87 | $23.88 | $23.38 | 270,600 | |
| $23.82 | +0.20 | +0.8% | $23.62 | $23.90 | $23.19 | 215,100 | |
| $23.62 | -0.63 | -2.6% | $24.08 | $24.22 | $23.33 | 353,800 | |
| $24.25 | 0.00 | 0.0% | $24.47 | $24.68 | $24.11 | 349,800 | |
| $24.25 | -0.12 | -0.5% | $24.51 | $24.66 | $24.00 | 309,400 | |
| $24.37 | -0.63 | -2.5% | $24.89 | $25.31 | $24.33 | 931,900 | |
| $25.00 | +0.50 | +2.0% | $24.97 | $25.25 | $24.49 | 734,900 | |
| $24.50 | -0.54 | -2.2% | $25.62 | $25.63 | $24.34 | 461,700 | |
| $25.04 | +0.71 | +2.9% | $24.42 | $25.12 | $23.90 | 323,300 | |
| $24.33 | +0.70 | +3.0% | $23.65 | $24.61 | $23.65 | 280,500 | |
| $23.63 | +0.20 | +0.9% | $23.65 | $23.65 | $23.04 | 255,100 | |
| $23.43 | -0.98 | -4.0% | $24.13 | $24.29 | $23.11 | 220,100 | |
| $24.41 | +0.10 | +0.4% | $24.00 | $24.66 | $23.65 | 255,300 | |
| $24.31 | -0.41 | -1.7% | $24.33 | $24.66 | $23.84 | 297,300 | |
| $24.72 | +0.15 | +0.6% | $24.57 | $24.88 | $24.25 | 223,600 | |
| $24.57 | -0.24 | -1.0% | $24.99 | $24.99 | $24.08 | 331,900 | |
| $24.81 | +0.23 | +0.9% | $24.66 | $25.07 | $24.24 | 502,800 | |
| $24.58 | +0.60 | +2.5% | $23.82 | $24.66 | $23.68 | 326,000 | |
| $23.98 | +0.25 | +1.1% | $23.66 | $23.98 | $23.07 | 282,700 | |
| $23.73 | +0.36 | +1.5% | $23.40 | $23.76 | $23.32 | 245,900 | |
| $23.37 | -0.08 | -0.3% | $23.40 | $23.96 | $23.32 | 160,600 | |
| $23.45 | -0.50 | -2.1% | $23.65 | $23.76 | $22.97 | 225,700 | |
| $23.95 | +0.01 | 0.0% | $24.18 | $24.24 | $23.65 | 243,383 | |
| $23.94 | -0.26 | -1.1% | $23.95 | $24.33 | $23.65 | 408,938 | |
| $24.20 | -0.11 | -0.5% | $24.31 | $24.33 | $23.80 | 292,600 | |
| $24.31 | -0.58 | -2.3% | $24.76 | $24.98 | $24.15 | 262,300 |
- Ticker
- NASDAQ:CBLL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Ceribell Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 3, 2026
CeriBell (NASDAQ:CBLL) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Q2 2026 Earnings Presentation
Earnings · 33 slides
Latest news
Ceribell Reports Third Quarter 2026 Financial Results
Nov 3, 2026
Closed $27.39 (-3.1%) on Nov 4, 2026
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Nov 2, 2026
Closed $26.96 (+1.4%) on Nov 2, 2026
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Oct 28, 2026
Closed $27.82 (+2.2%) on Oct 29, 2026
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Oct 20, 2026
Closed $27.14 (-2.0%) on Oct 21, 2026
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Sep 30, 2026
Closed $24.39 (-1.9%) on Sep 30, 2026
Ceribell Reports Second Quarter 2026 Financial Results
Aug 10, 2026
Closed $21.31 (+10.4%) on Aug 11, 2026
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
Aug 3, 2026
Closed $18.31 (+3.5%) on Aug 3, 2026
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe
Jul 30, 2026
Closed $17.64 (-0.5%) on Jul 30, 2026
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
Jul 28, 2026
Closed $17.73 (-0.6%) on Jul 29, 2026
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
Jul 20, 2026
Closed $17.89 (-2.9%) on Jul 21, 2026
CeriBell, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 23 in the last 12 months · 44 in all · newest Nov 3, 2026 · oldest 2024
- Calls
- 9 calls with a replay · 9 with a transcript · latest Nov 3, 2026
- Decks
- 3 decks · latest Aug 10, 2026
Where CeriBell, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CBLL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CBLL | BOATS | United States | USD |
Valuation
EV/sales 8.9× against a median of 3.9×: 9th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $967.9M USD
- P/E
- Loss
- EV/sales
- 8.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 9.1×
- Gross margin
- 89.3%
- Operating margin
- −69.8%
- Net margin
- −68.0%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 0.82
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CeriBell, Inc. · NASDAQ:CBLL | US$1.06B | US$967.9M | n/a | 8.9× | n/a | 9.1× | −68.0% | 0.2× | 0.82 |
| Eyebright Medical Technology (Beijing) Co., Ltd. Class A · SSE:688050 | US$1.18B | US$1.21B | 32.6× | 4.5× | n/a | 2.6× | 13.5% | 0.3× | n/a |
| Shandong Weigao Orthopaedic Device Co., Ltd. Class A · SSE:688161 | US$1.08B | US$895.1M | 30.3× | 4.3× | n/a | 1.7× | 17.2% | 0.0× | n/a |
| SI-BONE, Inc. · NASDAQ:SIBN | US$1.07B | US$1.07B | n/a | 4.8× | n/a | 5.8× | −6.2% | 0.2× | 0.62 |
| CLASSYS Inc. · KRX:214150 | US$1.06B | US$965.2M | 10.3× | 3.5× | 7.0× | 2.6× | 37.3% | 0.0× | n/a |
| Alphatec Holdings, Inc. · NASDAQ:ATEC | US$1.04B | US$1.51B | n/a | 1.8× | 31.6× | n/a | −10.3% | n/a | 1.26 |
| iRadimed Corporation · NASDAQ:IRMD | US$1.04B | US$972.8M | 43.2× | 10.9× | 31.9× | 9.7× | 26.9% | 0.0× | 0.65 |
| Shinva Medical Instrument Co. Ltd. Class A · SSE:600587 | US$1.04B | US$606.8M | 15.3× | 0.4× | n/a | 0.9× | 4.5% | 0.0× | n/a |
| Integra LifeSciences Holdings Corporation · NASDAQ:IART | US$1.03B | US$1.42B | 79.2× | 0.8× | n/a | 1.0× | 0.8% | 0.7× | 1.47 |
| Draegerwerk AG & Co. KGaA · XETR:DRW8 | US$985.7M | US$911.1M | 5.3× | 0.2× | 2.0× | 0.5× | 4.7% | 0.1× | n/a |
| Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675 | US$972.9M | US$695.9M | n/a | 10.2× | n/a | 2.8× | −19.4% | 0.0× | n/a |
| Median of the others | US$1.04B | US$969.0M | 30.3× | 3.9× | 19.3× | 2.6× | 4.6% | 0.0× | 0.96 |
Forecasts
7 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 31.57 USD · Analysts' mean
- EPS, year to Dec 2026
- -2.00 · 5 analysts
- Revenue, year to Dec 2026
- 115.8M · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jane Chao | President, Chief Executive Officer, Co-Founder, and Director |
| Scott Blumberg | Chief Financial Officer |
| Alex Grant | SVP, Engineering |
| Baharan Kamousi | SVP of Data Science |
| Dave Foehr | SVP of Finance |
| Kim McKeon | VP, People & Culture |
| Marc Gelnett | SVP, Operations |
| Vitas Sipelis | SVP, International General Manager |
| Erica Rogers | Executive |
| Josef Parvizi | Director, Co-Founder |
| Raymond Woo | Chief Technology Officer |
| Sean Manni | Chief Revenue Officer |
Board
| Director | Role |
|---|---|
| Rebecca Robertson | Director, Board Chair |
| Erica Rogers | Executive |
| Jane Chao | President, Chief Executive Officer, Co-Founder, and Director |
| Joseph M. Taylor | Director |
| Juliet Tammenoms Bakker | Director |
| Sharon L. O'Keefe | Director |
| Thomas A. West | Director |
| William W. Burke | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| CeriBell (NASDAQ:CBLL) Q3 2026 Earnings Call | Tue, Nov 03, 2026 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q2 2026 Earnings Call | Mon, Aug 10, 2026 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q1 2026 Earnings Call | Mon, May 11, 2026 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q1 2025 Earnings Call | Thu, May 08, 2025 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 4:30 PM ET | Replay |
| CeriBell (NASDAQ:CBLL) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 3, 2026 · After close | −3.1% |
| Q2 2026 | Aug 10, 2026 · After close | +10.4% |
| Q1 2026 | May 11, 2026 · After close | −16.5% |
| Q4 2025 | Mar 3, 2026 | −2.1% |
| Q3 2025 | Nov 4, 2025 · After close | +7.9% |
| Q2 2025 | Aug 5, 2025 · After close | −15.3% |
| Q1 2025 | May 8, 2025 · After close | −6.6% |
| Q4 2024 | Feb 25, 2025 | −0.9% |
| Q3 2024 | Nov 12, 2024 · After close | −3.4% |
| Q2 2024 | Aug 28, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 33 slides | Aug 10, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 32 slides | January 2026 |
| Investor Presentation (January 2025) | Investor deck | 28 slides | Jan 13, 2025 |
IPO
Priced at US$17.00 a share on Oct 10, 2024.
- Price
- US$17.00 a share
- Shares offered
- 10,606,060 shares of common stock
- Offering size
- US$180.3 million
- Underwriters' option
- Up to 1,590,909 more shares
- Listing
- CBLL on the Nasdaq Global Select Market
- Underwriters
- BofA Securities, J.P. Morgan, William Blair, TD Cowen, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Oct 15, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 24, 2024 |
| Filed publicly | Aug 26, 2024 |
| Amended 3 times | Newest Oct 9, 2024 |
| Shares registered with an exchange | Oct 8, 2024 |
| Declared effective by the SEC | Oct 10, 2024 |
| Final prospectus, with the price | Oct 11, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 11, 2024 |
| EFFECT · Notice that a registration is effective | Oct 10, 2024 |
| CERT · Exchange's certificate of listing | Oct 10, 2024 |
| FWP · Free writing prospectus | Oct 9, 2024 |
| CORRESP · Letter to the SEC | Oct 9, 2024 |
| S-1/A · Registration statement, amended | Oct 9, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 8, 2024 |
| CORRESP · Letter to the SEC | Oct 8, 2024 |
| CORRESP · Letter to the SEC | Oct 8, 2024 |
| UPLOAD · Letter from the SEC | Oct 8, 2024 |
All 21 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Oct 7, 2024 |
| CORRESP · Letter to the SEC | Sep 19, 2024 |
| S-1/A · Registration statement, amended | Sep 19, 2024 |
| UPLOAD · Letter from the SEC | Sep 11, 2024 |
| CORRESP · Letter to the SEC | Aug 26, 2024 |
| S-1 · Registration statement | Aug 26, 2024 |
| UPLOAD · Letter from the SEC | Aug 23, 2024 |
| DRSLTR · Letter to the SEC with a draft | Aug 5, 2024 |
| DRS/A · Draft registration statement, amended | Aug 5, 2024 |
| UPLOAD · Letter from the SEC | Jul 22, 2024 |
| DRS · Draft registration statement | Jun 24, 2024 |
Open IPO · From the cover of the final prospectus (424B4) filed Oct 11, 2024
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 89.1M | 65.4M | 45.2M | 25.9M |
| Cost of revenue | 10.8M | 8.69M | 7.06M | 4.43M |
| Gross profit | 78.3M | 56.8M | 38.2M | 21.5M |
| Research and development | 19.1M | 13.6M | 8.99M | 7.24M |
| Selling, general and administrative | 44.5M | 33.8M | 20.3M | 18.5M |
| Operating income | -58.4M | -39.7M | -30.0M | -36.0M |
| Depreciation and amortization | 1.34M | 1.14M | 847.0K | 497.0K |
| EBITDA | -57.1M | -38.6M | -29.2M | -35.5M |
| Interest expense | 1.89M | 1.99M | 2.10M | 1.60M |
| Income before tax | -53.4M | -40.5M | -29.5M | -37.2M |
| Income tax | 0 | 0 | 11.0K | 2.00K |
| Net income | -53.4M | -40.5M | -29.5M | -37.2M |
| Earnings per share, basic | -1.46 | -3.39 | -5.56 | -1.59 |
| Earnings per share, diluted | -1.46 | -3.39 | -5.56 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 40.5M | 194.4M | 34.5M | 68.2M |
| Short-term investments | 118.8M | 0 | ||
| Receivables | 15.1M | 10.9M | 7.96M | 5.29M |
| Inventory | 7.29M | 6.94M | 5.87M | 4.08M |
| Current assets | 186.7M | 217.3M | 52.0M | 79.8M |
| Property, plant and equipment | 2.03M | 2.31M | 1.58M | |
| Total assets | 195.8M | 225.4M | 58.9M | 86.5M |
| Accounts payable | 2.84M | 1.14M | 732.0K | 423.0K |
| Current liabilities | 19.2M | 13.0M | 21.6M | 9.86M |
| Long-term debt | 19.8M | 19.6M | 12.7M | |
| Total debt | 22.3M | 22.0M | 14.2M | 18.2M |
| Total liabilities | 40.5M | 34.2M | 23.8M | 172.9M |
| Shareholders' equity | 155.3M | 191.2M | -112.3M | -86.4M |
| Shares outstanding | 37.5M | 35.9M | 5.43M | 23.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -40.8M | -35.0M | -29.2M | -32.0M |
| Capital spending | -767.0K | -1.34M | -983.0K | -516.0K |
| Free cash flow | -41.6M | -36.4M | -30.1M | -32.5M |
| Cash from investing | -118.1M | -1.60M | -1.76M | -1.40M |
| Cash from financing | 5.05M | 196.5M | -2.82M | 49.8M |
| Share buybacks | 0 | -310.0K | ||
| Change in cash | -153.9M | 159.9M | -33.7M | 16.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 144/A · Notice of proposed sale, amended | Nov 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 9, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 3, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 3, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Nov 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 15, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 18, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 13, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 6, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 3 · Initial statement of ownership | Jul 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 30, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 29, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 7, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 30, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 10, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 2, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 22, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | May 21, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 12, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2026 | Results | SEC |
| 144 · Notice of proposed sale | May 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 6, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | May 5, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 1, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 20, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 20, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 20, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 24, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Feb 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 18, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 17, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 15, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 5, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 5, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 5, 2026 | Current report | SEC |
| 8-K · Current report | Jan 2, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jan 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Dec 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 22, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 15, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 12, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 11, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 9, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 9, 2025 | Current report | SEC |
| 144 · Notice of proposed sale | Dec 8, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 8, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 4, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Dec 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Nov 25, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 24, 2025 | Current report | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| S-3 · Registration statement | Nov 4, 2025 | Offer document | SEC |
| 4 · Change in ownership | Oct 7, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 3, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 24, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 22, 2025 | Management or board change | SEC |
| 3 · Initial statement of ownership | Sep 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 19, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 12, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
This page holds 200 of 314 filings. Open Filings
Cap table
Built by 6ix from CeriBell, Inc.’s releases · as of Oct 30, 2026
- Common shares
- 38,835,010
- Fully diluted
- 38,835,010
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 38,835,010 | Oct 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 30, 2026 | 38,835,010 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Erica Rogers Other companies: Sight Sciences, Inc. (Director · Since at least Jun 8, 2022); Lucira Health Inc (Director · Jun 1, 2022 – Jun 1, 2022 · Past); Silk Road Medical Inc (President and CEO, Director · Apr 11, 2022 – Sep 29, 2023 · Past) | Executive · Since at least Sep 17, 2025 |
| Thomas A. West Other companies: SI-BONE, Inc. (Director · Since at least Jun 25, 2024); Inogen, Inc (Director · Jun 5, 2024 – Jun 5, 2024 · Past) | Director · Since at least Jul 28, 2026 |
| William W. Burke Other companies: Covista Inc. (Director · Since at least Nov 5, 2026); Tactile Systems Technology, Inc. (CHAIRMAN · Since at least May 6, 2026) | Director · Since at least Jun 2, 2026 |
| Joseph M. Taylor Other companies: Factorial Energy Inc. (Director · Since at least Jun 5, 2026) | Director · Since at least Oct 10, 2024 |
| Rebecca Robertson Other companies: Tandem Diabetes Care, Inc. (Director · Since at least Jan 2, 2019) | Director · Since at least Oct 10, 2024 |
| Sharon L. O'Keefe Other companies: Covista Inc. (Director · Since at least Nov 5, 2026) | Director · Since at least Jul 28, 2026 |
| Alex Grant | SVP, Engineering · Since at least Nov 4, 2026 |
| Baharan Kamousi | SVP of Data Science · Since at least Nov 5, 2026 |
| Dave Foehr | SVP of Finance · Since at least Sep 10, 2026 |
| David Foehr | Senior VP, Finance and PAO · Since at least Oct 10, 2024 |
All 20 people
| Person | Seat |
|---|---|
| Jane Chao | President, Chief Executive Officer, Co-Founder, and Director · Since at least Nov 3, 2026 |
| Josef Parvizi | Director, Co-Founder · Since at least Oct 10, 2024 |
| Juliet Tammenoms Bakker | Director · Since at least Nov 5, 2026 |
| Kim McKeon | VP, People & Culture · Since at least Nov 5, 2026 |
| Marc Gelnett | SVP, Operations · Since at least Nov 5, 2026 |
| Raymond Woo | Chief Technology Officer · Since at least Oct 10, 2024 |
| Scott Blumberg | Chief Financial Officer · Since at least Oct 10, 2024 |
| Sean Manni | Chief Revenue Officer · Since at least Nov 5, 2026 |
| Vitas Sipelis | SVP, International General Manager · Since at least Nov 5, 2026 |
| Xingjuan Chao | President and CEO, Director · Since at least Oct 10, 2024 |
Log in to ask 6ix AI your own questions about CeriBell, Inc.